The findings suggest that exogenous insulin promotes pro-inflammatory macrophage responses independent of markers of hepatic cholesterol processing [13], consistent with earlier clinical findings of increased inflammatory markers in coronary atherectomy specimens from DM patients [14]. The gene discussed is INS; the disease is diabetes mellitus.